AVELOX 400MG/250ML IV
Sterile soln. for infusion
Moxifloxacin Hydrochloride 436.80mg equiv to 400mg in 250ml of sterile sol for infusion.
Treatment of infections caused by germs sensitive to moxifloxacin.
Avelox IV is indicated for the treatment of adults (> 18 years old) with upper and lower respiratory infections such as: acute sinusitis; acute exacerbations of chronic bronchitis; community-acquired pneumonia, as well as skin and soft tissue infections.
400mg (1 tablet or 1 bag x 60 min) 1 v / day in all indications. Usually for upper and lower respiratory tract. Acute exacerbation of chronic bronchitis 5 days. Community acquired pneumonia 7-14 days. Acute sinusitis 7 days. Recommended treatment duration for skin and soft tissue infections 7 days.
Hypersensitivity to quinolones. Pregnancy and breastfeeding. Patients <18 years of age, due to the fact that quinolones have caused irreversible joint damage in toxicological studies.